Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) is scheduled to announce its earnings results after the market closes on Tuesday, November 7th.

Cumberland Pharmaceuticals (NASDAQ:CPIX) last issued its quarterly earnings data on Tuesday, August 8th. The specialty pharmaceutical company reported ($0.07) earnings per share (EPS) for the quarter. Cumberland Pharmaceuticals had a negative return on equity of 0.13% and a negative net margin of 19.57%. The company had revenue of $8.67 million for the quarter.

Shares of Cumberland Pharmaceuticals Inc. (NASDAQ CPIX) opened at $7.61 on Friday. The company has a current ratio of 4.88, a quick ratio of 4.45 and a debt-to-equity ratio of 0.10. Cumberland Pharmaceuticals Inc. has a 12-month low of $4.93 and a 12-month high of $7.77.

ILLEGAL ACTIVITY NOTICE: This story was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The legal version of this story can be viewed at

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company’s product portfolio includes Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) Injection for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution for the treatment of chronic and acute constipation; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H.

Earnings History for Cumberland Pharmaceuticals (NASDAQ:CPIX)

Receive News & Stock Ratings for Cumberland Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals Inc. and related stocks with our FREE daily email newsletter.